BUGLIONE DI MONALE E BASTIA, Michela
 Distribuzione geografica
Continente #
NA - Nord America 11.214
AS - Asia 4.824
EU - Europa 4.494
SA - Sud America 928
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 14
Totale 21.585
Nazione #
US - Stati Uniti d'America 11.054
SG - Singapore 1.669
CN - Cina 1.664
UA - Ucraina 1.005
BR - Brasile 809
DE - Germania 796
HK - Hong Kong 646
IT - Italia 633
PL - Polonia 609
FI - Finlandia 340
GB - Regno Unito 262
RU - Federazione Russa 249
TR - Turchia 226
VN - Vietnam 209
IE - Irlanda 188
FR - Francia 167
IN - India 123
CA - Canada 83
BD - Bangladesh 55
ZA - Sudafrica 48
AR - Argentina 46
MX - Messico 45
SE - Svezia 44
ID - Indonesia 42
CZ - Repubblica Ceca 41
IQ - Iraq 34
JP - Giappone 29
NL - Olanda 26
ES - Italia 25
EC - Ecuador 24
AT - Austria 21
BE - Belgio 19
UZ - Uzbekistan 18
PK - Pakistan 15
CO - Colombia 14
EU - Europa 14
SA - Arabia Saudita 14
LT - Lituania 13
MA - Marocco 13
VE - Venezuela 13
AU - Australia 12
GR - Grecia 9
IR - Iran 8
BY - Bielorussia 7
IL - Israele 7
JO - Giordania 7
KE - Kenya 7
PY - Paraguay 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
JM - Giamaica 6
KG - Kirghizistan 6
MY - Malesia 6
PA - Panama 6
AL - Albania 5
CH - Svizzera 5
EG - Egitto 5
OM - Oman 5
TW - Taiwan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
DK - Danimarca 3
KH - Cambogia 3
KR - Corea 3
KW - Kuwait 3
KZ - Kazakistan 3
MU - Mauritius 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
AM - Armenia 2
CR - Costa Rica 2
EE - Estonia 2
HU - Ungheria 2
IS - Islanda 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
SL - Sierra Leone 2
SN - Senegal 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
LU - Lussemburgo 1
Totale 21.577
Città #
Fairfield 1.304
Ashburn 1.092
Woodbridge 1.085
Singapore 819
Jacksonville 727
Houston 691
Hong Kong 641
Warsaw 600
Seattle 570
Cambridge 540
Chandler 535
Ann Arbor 495
Wilmington 472
Beijing 404
Princeton 337
New York 330
Nanjing 211
Los Angeles 208
Dublin 187
Helsinki 183
Dearborn 178
Istanbul 173
Munich 145
Dallas 120
Brescia 106
The Dalles 104
Nanchang 91
Shanghai 90
Buffalo 88
Des Moines 88
Moscow 83
São Paulo 82
San Francisco 76
Milan 74
San Diego 71
Changsha 61
Ho Chi Minh City 57
Dong Ket 52
Shenyang 51
Jinan 50
Hebei 49
Tianjin 48
Turku 47
Redondo Beach 46
Washington 45
London 44
Chicago 43
Boardman 42
Santa Clara 38
Jiaxing 37
Kunming 34
Hanoi 30
Johannesburg 29
Nuremberg 29
Brooklyn 28
Denver 28
Hangzhou 28
Jakarta 28
Montreal 28
Toronto 27
Brno 26
Poplar 26
Rio de Janeiro 26
Tokyo 26
Lancaster 25
Zhengzhou 23
Ningbo 21
Phoenix 21
Chennai 20
Orem 20
Brussels 19
Brasília 18
Kocaeli 18
Tashkent 17
Atlanta 16
Ceto 16
Guangzhou 16
Haikou 16
Mexico City 16
Rome 16
Stockholm 16
Taizhou 16
Boston 15
Nürnberg 15
Verona 15
Ankara 14
Baronissi 14
Dhaka 14
Frankfurt am Main 14
Lanzhou 14
Norwalk 13
Quito 13
Changchun 12
Charlotte 12
Curitiba 12
Manchester 12
Pune 12
Redwood City 12
Romola 12
Belo Horizonte 11
Totale 14.669
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 254
Correlation between Human Papillomavirus Status and Quantitative MR Imaging Parameters including Diffusion-Weighted Imaging and Texture Features in Oropharyngeal Carcinoma 254
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 237
Overexpression of sialidase NEU3 increases the cellular radioresistance potential of U87MG glioblastoma cells 233
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 230
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 206
Pros-IT CNR: an Italian prostate cancer monitoring project 205
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 205
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 190
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 190
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 187
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 184
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 181
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 177
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 176
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 176
Radiotherapy in patients with HIV: current issues and review of the literature 176
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 171
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 168
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 167
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 165
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 165
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 165
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 162
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 160
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 160
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 159
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 158
Role of external beam radiotherapy in the treatment of relapsing meningioma 157
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 156
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 156
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 156
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 156
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 155
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 155
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 154
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 152
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 152
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 149
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 149
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 149
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 147
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 146
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 145
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 144
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 143
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 143
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 143
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 143
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 142
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 142
From Molecular to Clinical Radiation Biology of Glioblastoma 142
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 141
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 140
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 139
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 138
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 137
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 137
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 136
Letter to “Medial lingual lymph node metastasis in carcinoma of the tongue” 135
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 133
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 133
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 133
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 133
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 132
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 132
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 132
Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection? 132
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 131
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 130
Information Retrieval in Medicine: an Extensive Experimental Study 129
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 128
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 127
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 126
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 126
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 125
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 125
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 124
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 124
Cetuximab and Radiation Therapy in Head and Neck Cancer 123
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 122
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 120
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 119
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 118
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 118
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 118
Post-ABVD/pre-radiotherapy 18F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: A retrospective analysis on 165 patients 118
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 117
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 117
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 117
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 116
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 115
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 115
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 115
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 114
Nasopharyngeal carcinoma 114
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 113
Practical prognostic score for predicting the extent of resection and neurological outcome of gliomas in the sensorimotor area 113
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 113
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. 112
Totale 14.842
Categoria #
all - tutte 107.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.957 0 0 0 0 0 357 113 316 320 394 262 195
2021/20221.355 110 197 38 58 16 75 54 113 75 161 86 372
2022/20231.362 188 88 47 103 126 339 6 138 214 17 53 43
2023/20241.813 87 32 192 94 97 413 64 80 350 53 79 272
2024/20253.375 31 41 29 491 333 300 285 139 317 286 725 398
2025/20263.855 680 915 493 936 762 69 0 0 0 0 0 0
Totale 21.991